Pain management
Ended Awarded Last action
- Contract number
- SPE2D626F45Q4
- Awardee
-
Boston Scientific Neuromodulation Corp UEI LQBMUJMLS256 Part of Boston Scientific Corp
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $43,710
Award facts
- Contract value 100% obligated
- $43,709.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Fixed Price with Economic Price Adjustment
- Place of performance
- Valencia, CA 91355, USA
Award details come from SAM.gov/FPDS.
About this award
Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a fixed-price delivery order valued at $43,709.82 on December 15, 2025, for pain management medical devices and equipment. The delivery order, with a ultimate completion date of December 22, 2025, will be performed in Valencia, California, and is funded by the Defense Logistics Agency's Medical Supply Chain, a defense-related procurement entity within the Department of Defense. This award carries no small business set-aside designation, allowing the contractor to compete on an unrestricted basis. The delivery order is issued under Boston Scientific Neuromodulation Corp's existing single-award indefinite delivery contract with DLA Troop Support Medical (Program acronym SPE2DE, valued at $83.1M through August 2026), which enables the company to provide comprehensive neuromodulation solutions including spinal cord stimulation systems, implantable pain pumps, radiofrequency ablation devices, and associated accessories and technical support to military treatment facilities and VA medical centers nationwide.
This delivery order supports the federal government's commitment to providing non-opioid pain management technologies for service members and veterans managing chronic pain from traumatic injuries. Boston Scientific Neuromodulation Corp specializes in advanced medical technologies focused on neuromodulation therapies and has consistently demonstrated capability in delivering sophisticated pain management medical devices to Defense and Veterans Affairs facilities. The parent company, Boston Scientific Corp, is a global medical technology leader headquartered in Marlborough, Massachusetts, with extensive federal contracting experience across multiple therapeutic areas and a strong track record of supporting federal healthcare agencies through innovative medical device solutions.
Quick answers
Who was awarded contract SPE2D626F45Q4?
SPE2D626F45Q4 was awarded to Boston Scientific Neuromodulation Corp by Medical Supply Chain (Troop Support) on December 15, 2025.
How much is contract SPE2D626F45Q4 worth?
The government has obligated $43,710 on SPE2D626F45Q4.
Is contract SPE2D626F45Q4 an order under another contract?
Yes. SPE2D626F45Q4 is a delivery order under SPE2DE21D7009, an indefinite delivery contract.
Was contract SPE2D626F45Q4 competed?
The extent of competition for SPE2D626F45Q4 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award